Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Asset Writedowns and Impairment: 2019-2020

Historic Asset Writedowns and Impairment for Outlook Therapeutics (OTLK) over the last 2 years, with Sep 2020 value amounting to $527,624.

  • Outlook Therapeutics' Asset Writedowns and Impairment rose 104.80% to $104,296 in Q2 2020 from the same period last year, while for Jun 2020 it was $9.1 million, marking a year-over-year change of. This contributed to the annual value of $527,624 for FY2020, which is 95.33% down from last year.
  • As of FY2020, Outlook Therapeutics' Asset Writedowns and Impairment stood at $527,624, which was down 95.33% from $11.3 million recorded in FY2019.
  • Outlook Therapeutics' 5-year Asset Writedowns and Impairment high stood at $11.3 million for FY2019, and its period low was $527,624 during FY2020.
  • Moreover, its 2-year median value for Asset Writedowns and Impairment was $5.9 million (2019), whereas its average is $5.9 million.
  • Data for Outlook Therapeutics' Asset Writedowns and Impairment shows a maximum YoY tumbled of 95.33% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows Outlook Therapeutics' Asset Writedowns and Impairment stood at $11.3 million in 2019, then slumped by 95.33% to $527,624 in 2020.